Our ambition is to be a catalyst for positive change and a leader in environmental sustainability. Our continued investment in our planet supports our purpose to reimagine medicine to improve and extend people’s lives. It is also a way to build trust with society, if our actions are guided by a commitment to transparency and creating enduring change.
Novartis at COP26
Planetary health is human health
The planetary emergency is creating a human health crisis we cannot ignore. In her NY Times article, our Chief Sustainability Officer, Montse Montaner, explains why the time to act is now.
Blue-sky thinking
The race to net zero emissions is a challenging one. We are implementing renewable energy programs and natural climate solutions to support our journey.
Decarbonizing supply chains
We are joining 9 other pharma companies to launch Energize, a program to increase access to renewable energy for our suppliers.
Our Commitments
People
We will encourage associates across our operations to adopt an environmental sustainability mindset.
Patients
We will work to understand how a changing climate will impact people's health and deliver environmentally sustainable medicines.
Planet
We will minimize the impact of our actions on the planet and invest in environmental solutions that also protect biodiversity.
Our Strategy and Targets
We aim to drive sustainability through our own operations, as well as those of our suppliers, and we have set ambitious targets to minimize our impacts on climate, waste and water.
In 2021, we committed to becoming Net Zero by 2040. We are currently in the process of aligning our strategy and targets to the new Science Based Targets (SBT) Net Zero Standard published in October 2021.
Our 2021 Performance
34%
reduction in greenhouse gas emissions (Scope 1 and 2) vs. 2016
40%
reduction in water consumption vs. 2016
56%
reduction in waste disposal vs. 2016
Environmental sustainability reporting
We take our responsibility to protect the environment seriously. We publish several key pieces of information about our efforts to reduce our impacts on the environment.
Novartis in Society Integrated Report 2021
The Novartis in Society Integrated Report covers our business, strategy and performance, including on environmental, social and governance topics.
Novartis Health, Safety and Environment (HSE) Data 2016-2021
HSE data is collected and reviewed on a quarterly basis. This data table will be updated with actual data in H1 2022.
CDP Disclosure 2021
Each year we disclose our submissions to the CDP on climate change and water. CDP is a not-for-profit charity that runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impacts.
Novartis HSE Data Supplement 2020
During the first half of each year, we publish a supplement offering more details on our sustainability strategy and performance following Global Reporting Initiative (GRI) guidelines.